MGC Pharmaceuticals Ltd is an EU based specialist medical cannabis company with many years of technical and commercial experience in the medical cannabis industry. The company's founders were key figures in the Israeli medical cannabis industry and the core business strategy is to develop and supply high quality nonpsychoactive cannabidiol (CBD) resin extract for the growing demand in cosmetics and medical markets in Europe, North America and Australasia. The company is also developing strategic joint ventures in these key value-add industries, as demonstrated with MGC Derma CBD cosmetics.